Table of Contents for the Digital Edition of Drug Information Journal - September 2009 Drug Information Journal - September 2009 Contents Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions Qualified Statisticians in the European Pharma Industry: Present and Future Directions Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker Repeated Measures Analyses in Clinical Trials With Titration Visits Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety Perception of Risk Through Phases of Drug Research and Development Good Pharmacovigilance Practice Review of Targeted Regulatory Writing Techniques Drug Information Journal - September 2009 Drug Information Journal - September 2009 - (Page Intro) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page Cover1) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page Cover2) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page A) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page B) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page C) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page D) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page E) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page F) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page G) Drug Information Journal - September 2009 - Drug Information Journal - September 2009 (Page H) Drug Information Journal - September 2009 - Contents (Page I) Drug Information Journal - September 2009 - Contents (Page J) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 525) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 526) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 527) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 528) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 529) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 530) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 531) Drug Information Journal - September 2009 - Three Persistent Issues in Analysis of Clinical Trials Involving Diagnostic Contrast Agents (Page 532) Drug Information Journal - September 2009 - Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials (Page 533) Drug Information Journal - September 2009 - Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials (Page 534) Drug Information Journal - September 2009 - Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials (Page 535) Drug Information Journal - September 2009 - Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials (Page 536) Drug Information Journal - September 2009 - Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials (Page 537) Drug Information Journal - September 2009 - Compliance Analysis as Additional Evidence for Efficacy in Clinical Trials (Page 538) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 539) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 540) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 541) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 542) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 543) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 544) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 545) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 546) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 547) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 548) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 549) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 550) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 551) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 552) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 553) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 554) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 555) Drug Information Journal - September 2009 - Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development (Page 556) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 557) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 558) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 559) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 560) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 561) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 562) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 563) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 564) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 565) Drug Information Journal - September 2009 - Unconditional Exact Tests for Dichotomous Data in the Comparison of Two Treatments With One Control Group (Page 566) Drug Information Journal - September 2009 - A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions (Page 567) Drug Information Journal - September 2009 - A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions (Page 568) Drug Information Journal - September 2009 - A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions (Page 569) Drug Information Journal - September 2009 - A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions (Page 570) Drug Information Journal - September 2009 - A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions (Page 571) Drug Information Journal - September 2009 - A Study of the Classical Asymptotic Noninferiority Test for Two Binomial Proportions (Page 572) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 573) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 574) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 575) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 576) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 577) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 578) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 579) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 580) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 581) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 582) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 583) Drug Information Journal - September 2009 - Qualified Statisticians in the European Pharma Industry: Present and Future Directions (Page 584) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 585) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 586) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 587) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 588) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 589) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 590) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 591) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 592) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 593) Drug Information Journal - September 2009 - Weibull Failure-Time Mixture Models for Evaluating Efficacy in the Presence of a Biomarker (Page 594) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 595) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 596) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 597) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 598) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 599) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 600) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 601) Drug Information Journal - September 2009 - Repeated Measures Analyses in Clinical Trials With Titration Visits (Page 602) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 603) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 604) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 605) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 606) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 607) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 608) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 609) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 610) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 611) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 612) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 613) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 614) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 615) Drug Information Journal - September 2009 - Constant Vigilance: The Role of Pharmaceutical Companies in Medicine Safety (Page 616) Drug Information Journal - September 2009 - Perception of Risk Through Phases of Drug Research and Development (Page 617) Drug Information Journal - September 2009 - Perception of Risk Through Phases of Drug Research and Development (Page 618) Drug Information Journal - September 2009 - Perception of Risk Through Phases of Drug Research and Development (Page 619) Drug Information Journal - September 2009 - Perception of Risk Through Phases of Drug Research and Development (Page 620) Drug Information Journal - September 2009 - Perception of Risk Through Phases of Drug Research and Development (Page 621) Drug Information Journal - September 2009 - Perception of Risk Through Phases of Drug Research and Development (Page 622) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 623) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 624) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 625) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 626) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 627) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 628) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 629) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 630) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 631) Drug Information Journal - September 2009 - Good Pharmacovigilance Practice (Page 632) Drug Information Journal - September 2009 - Review of Targeted Regulatory Writing Techniques (Page 633) Drug Information Journal - September 2009 - Review of Targeted Regulatory Writing Techniques (Page 634) Drug Information Journal - September 2009 - Review of Targeted Regulatory Writing Techniques (Page Cover3) Drug Information Journal - September 2009 - Review of Targeted Regulatory Writing Techniques (Page Cover4) http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0910 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0710 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0510 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0310 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0110 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0909 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0709 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0509 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0309 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0109 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0908 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0708 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0508 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0308 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0108 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal1107 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0907 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0707 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0507 http://www.nxtbook.com/nxtbooks/dia/druginformationjournal0307 http://www.nxtbookMEDIA.com
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.